NCT03429881 is a NA clinical trial of Stripping versus laser CO2 in Microparticle, sponsored by Francisco Carmona.

Who is sponsoring NCT03429881?

NCT03429881 is sponsored by Francisco Carmona.

What drugs are being tested in NCT03429881?

Interventions in NCT03429881: Stripping versus laser CO2.

What condition does NCT03429881 study?

NCT03429881 studies Microparticle, Endometriosis, Laparoscopy.

Is NCT03429881 still recruiting?

NCT03429881 is currently completed. Last updated 12 February 2018.

Last reviewed 2018-02-12 · How we verify

NCT03429881

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Microparticle Generation After Laparoscopic Surgical Treatment for Endometrioma.

Completed NA Last updated 12 February 2018

What this trial tests

NA trial testing Stripping versus laser CO2 in Microparticle in 33 participants. Completed in 5 February 2018.

Timeline

5 February 2018

Primary endpoint
5 February 2018

5 February 2018

Quick facts

Lead sponsor	Francisco Carmona
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	basic science
Enrollment	33
Start date	5 February 2018
Primary completion	5 February 2018
Estimated completion	5 February 2018
Sites	1 location across Spain

Drugs / interventions tested

Stripping versus laser CO2

Conditions studied

Microparticle — all drugs for Microparticle →
Endometriosis — all drugs for Endometriosis →
Laparoscopy — all drugs for Laparoscopy →

Sponsor

Francisco Carmona

Who can join

Adults 18 to 40, female only, with Microparticle or Endometriosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Study objective: To evaluate serial generation of microparticles (MPs) after laparoscopic stripping or CO2 laser vaporization in surgical treatment of patients with ovarian endometrioma (OE). Design: A prospective, randomized, blinded, pilot study, including 33 patients. Setting: Tertiary university hospital from April 2015 to June 2017. Patients: 33 women with unilateral OE undergoing laparoscopic surgery. Intervention: Patients were randomly selected to undergo either CO2 laser vaporization (L group) or laparoscopic stripping (S group) of OE. Measurements and Main results: Blood samples were collected before surgery, and at 2 hours, 24 hours, 1 month, and 3 months after surgery. MPs generation curve after ovarian endometrioma surgery was performed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03429881 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Francisco Carmona
Last refreshed: 12 February 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03429881.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing